Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel
Comprehensive genetic test evaluating key genes linked to inherited arrhythmias and cardiomyopathies. Helps clarify diagnosis, guide management, and assess familial risk.
Accessed through the Invitae Unlock™ Sponsored Testing Program•Sponsored by Invitae | Labcorp•Performed by Invitae | Labcorp
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
The Invitae Unlock Cardiomyopathy and Arrhythmia Program removes a key access barrier by backstopping the cost of the Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel when a patient's insurance denies the claim or the patient is uninsured. A single order covers 100 genes spanning inherited cardiomyopathy and inherited arrhythmia, supporting diagnostic clarification, risk stratification, and cascade testing in one workflow. Participation carries no obligation to recommend, prescribe, or support any other products or services from Invitae or third parties.
When to consider this test
Patient selection
- To qualify, all of the following must be met:
- Resides in the United States
- Suspected of having a familial cardiomyopathy or arrhythmia — at least one of the following:
- Suspicion or known diagnosis of a familial cardiomyopathy or arrhythmia (e.g. HCM, DCM, ARVC, LVNC, LQTS, CPVT, BrS)
- Family history of a primary cardiomyopathy or arrhythmia
- Family history of unexplained sudden cardiac death
- Ordered by a qualified healthcare provider
Workflow
How to use this program
- 1
Submit an order
Place the order online or via paper TRF. Include the patient’s insurance information for benefits investigation.
- 2
Collect specimen
Collect a blood, buccal, or saliva specimen using a Labcorp kit and follow standard collection procedures.
- 3
Receive results
Turnaround time is typically 10–21 days from specimen receipt. Results will be available through your Labcorp portal.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Invitae | Labcorp, a CLIA-certified laboratory (CLIA 05D2040778). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
Which patients are appropriate for the Invitae Unlock Cardiomyopathy and Arrhythmia Program?
The Invitae Unlock Cardiomyopathy and Arrhythmia Program is available to U.S. patients with suspected inherited cardiomyopathy or inherited arrhythmia who meet the program's eligibility criteria. Healthcare professionals must confirm that patients satisfy these criteria at the time of ordering. The program supports diagnostic workup, risk assessment, and family variant identification across the cardiomyopathy and arrhythmia spectrum.
What genes and conditions does the Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel cover?
The Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel interrogates 100 genes associated with inherited cardiomyopathy and inherited arrhythmia conditions using next-generation sequencing. By combining both condition groups into a single panel, the test reduces the need for sequential orders and can surface findings across overlapping phenotypes in one result set.
How does billing work for the Invitae Unlock cardiomyopathy and arrhythmia genetic testing program?
The Invitae Unlock Cardiomyopathy and Arrhythmia Program bills the patient's insurance first. If the claim is denied or the patient is uninsured, the program sponsor covers the cost of testing. For approved claims, testing is processed under the patient's plan as usual; direct any cost-sharing questions to the patient's insurance or billing team.
What specimen types and turnaround time apply to the Invitae Unlock cardiomyopathy and arrhythmia panel?
The Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel accepts whole blood, saliva, buccal swab, or extracted gDNA. Testing is performed by Invitae at Labcorp, with results typically returned in 10 to 21 days from specimen receipt. Kits and collection logistics can be coordinated through the Invitae ordering portal.
Does ordering through the Invitae Unlock Cardiomyopathy and Arrhythmia Program create any prescribing or purchasing obligation?
No. Healthcare professionals and patients who participate in the Invitae Unlock Cardiomyopathy and Arrhythmia Program have no obligation to recommend, purchase, order, prescribe, promote, administer, use, or support any other products or services from Invitae or from third parties or commercial organizations. The program is designed solely to support access to genetic testing for inherited cardiomyopathy and arrhythmia.
Are genetic counseling resources available through the Invitae Unlock cardiomyopathy and arrhythmia testing program?
Yes. The Invitae Unlock Cardiomyopathy and Arrhythmia Program provides access to genetic counseling support and clinical resources, including gene-specific management guides and educational webinars. Providers can also consult with Invitae's genetic counseling team for pre- or post-test guidance on complex cases.
Which patients are eligible for Invitae Unlock Inherited Cardiomyopathy genetic testing?
Patients may qualify for Invitae Unlock if they meet the program's eligibility criteria:
- Patient must reside in the United States.
- Patient should have clinical suspicion for a familial cardiomyopathy or inherited arrhythmia.
- Postmortem specimens are not eligible for testing under this program.
See an issue with this program?